Are 30-Day Outcomes Enough? Late Infectious Readmissions following Prosthetic-Based Breast Reconstruction
Authors:
- 1 September 2019
- journal article
- conference paper
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 144 (3) , 360e-368e
Abstract
Background: Surgical-site infection is a major concern in prosthetic-based breast reconstruction. Thirty-day postoperative readmission rates are a common quality metric, but little is known about readmission rates for later infections. Methods: Using the 2013 to 2014 Nationwide Readmissions Database, the authors identified breast cancer patients undergoing breast reconstruction with implants and tissue expanders who had an infectious readmission. The authors used univariate and multivariate logistic regression models to identify predictors of infectious readmission and explantation within the early (0 to 30 days) and late (31 to 90 days) postoperative periods. Results: In the weighted sample, the authors identified 18,338 patients undergoing prosthetic-based breast reconstruction. The overall infectious readmission rate was 4.1 percent (n = 759): 49.3 percent occurred early and 50.7 percent occurred late. Of the infectious readmissions, 39.5 percent required explantation, 55.1 percent of which occurred during a late infectious readmission. Seventy-five percent of these infectious readmissions and explantations occurred within 49 days of initial surgery. Median annual household income less than $40,000 (p = 0.035), diabetes (p = 0.038), and obesity (p = 0.004) were independent predictors of infectious readmission. Diabetes (p = 0.049) and hypertension (p = 0.011) were independent predictors of early readmission. Median annual household income less than $40,000 (p = 0.049), obesity (p = 0.006), and increasing length of stay during the index procedure (p = 0.028) were independent predictors of late readmission. No statistically significant independent predictors for explantation were identified. Conclusions: Traditional 30-day readmission rates are not an adequate quality metric for breast reconstruction given the number of late postoperative readmissions, many of which lead to explantation. Early and late infectious readmissions have different predictors. Interventions targeting these predictors may decrease the number of readmissions, thus reducing cost and improving quality. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, III.Keywords
This publication has 26 references indexed in Scilit:
- Infection following Implant-Based Reconstruction in 1952 Consecutive Breast ReconstructionsPlastic and Reconstructive Surgery, 2013
- Risk factors for surgical site infections after breast surgery: A systematic review and meta-analysisEuropean Journal of Surgical Oncology, 2012
- Interventions to Reduce 30-Day Rehospitalization: A Systematic ReviewAnnals of Internal Medicine, 2011
- Postoperative Hyperglycemia and Surgical Site Infection in General Surgery PatientsArchives of Surgery, 2010
- Hyperglycemia as a risk factor for surgical site infections in patients undergoing mastectomyAmerican Journal of Infection Control, 2008
- Hospital-Associated Costs Due to Surgical Site Infection After Breast SurgeryArchives of Surgery, 2008
- Long-term Glycemic Control and Postoperative Infectious ComplicationsArchives of Surgery, 2006
- Infectious Complications following Breast Reconstruction with Expanders and ImplantsPlastic and Reconstructive Surgery, 2003
- The Premature Removal of Tissue Expanders in Breast ReconstructionPlastic and Reconstructive Surgery, 1999
- On Chi-Squared Tests for Multiway Contingency Tables with Cell Proportions Estimated from Survey DataThe Annals of Statistics, 1984